These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 89620)
61. Elimination of human immunodeficiency virus from immunoglobulin preparations. Lancet; 1986 May; 1(8491):1217-8. PubMed ID: 2422515 [No Abstract] [Full Text] [Related]
62. [Content of antibodies to certain cardiotropic strains of enteral viruses in commercial gamma-globulin preparations]. Venediktova NIa; Khovanova AM; Kolpakova VE; Patsuk NV; Deĭch SB Zh Mikrobiol Epidemiol Immunobiol; 1975 Aug; (8):147-8. PubMed ID: 53971 [No Abstract] [Full Text] [Related]
63. [Virus infection in the clinic]. Goetz O Monatsschr Kinderheilkd (1902); 1977 May; 125(5):273-5. PubMed ID: 69260 [No Abstract] [Full Text] [Related]
64. Additional commercial gammaglobulin preparations found with antibody to human immunodeficiency virus. Hausler WJ; Swack NS; Ramirez MT J Infect Dis; 1990 Jan; 161(1):153. PubMed ID: 1688600 [No Abstract] [Full Text] [Related]
65. [Inherent specific immunity as basis for preventive and therapeutic use of homologous antibodies]. AUERSWALD W Wien Z Inn Med; 1954 Apr; 35(4):157-63. PubMed ID: 13196374 [No Abstract] [Full Text] [Related]
66. Immune thrombocytopenia gammaglobulin, and positivity to the human T-lymphotropic virus type III. Laurian Y; Le Bras P; Ellrodt A; Alvin P Ann Intern Med; 1986 Jul; 105(1):145-6. PubMed ID: 2424352 [No Abstract] [Full Text] [Related]
67. [Tolerance of a new intravenously applied immunoglobulin preparation and its effect on serum globulin levels]. Hansi W; Heimpel H; Barandun S; Lutz O Infection; 1982; 10(6):347-51. PubMed ID: 6185438 [TBL] [Abstract][Full Text] [Related]